Brateil Badal
Overview
Explore the profile of Brateil Badal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang L, Badal B, Lu C, Solovyov A, Greenbaum B, Celebi J
Melanoma Res
. 2020 Sep;
30(6):594-598.
PMID: 32976222
Mounting evidence supports a role for dysregulated long non-coding RNAs (lncRNA) in the development of many cancers. A recently discovered function of lncRNAs is to act as microRNA (miR) decoys...
2.
Chang L, Iqbal R, Badal B, Bernstein D, Mendelson K, Solovyov A, et al.
Pigment Cell Melanoma Res
. 2020 Feb;
33(4):633-636.
PMID: 32096295
No abstract available.
3.
Abbate F, Badal B, Mendelson K, Aydin I, Serasinghe M, Iqbal R, et al.
Pigment Cell Melanoma Res
. 2018 Apr;
31(5):636-640.
PMID: 29665239
FBXW7 is well characterized as a tumor suppressor in many human cancers including melanoma; however, the mechanisms of tumor-suppressive function have not been fully elucidated. We leveraged two distinct RNA...
4.
Serasinghe M, Gelles J, Li K, Zhao L, Abbate F, Syku M, et al.
Cell Death Dis
. 2018 Jan;
9(2):29.
PMID: 29348439
Mitogen-activated protein kinase (MAPK) pathway inhibitors show promise in treating melanoma, but are unsuccessful in achieving long-term remission. Concordant with clinical data, BRAF melanoma cells eliminate glycolysis upon inhibition of...
5.
Aydin I, Abbate F, Rajan G, Badal B, Aifantis I, Desman G, et al.
Pigment Cell Melanoma Res
. 2017 Jun;
30(6):571-574.
PMID: 28581198
No abstract available.
6.
Badal B, Solovyov A, Di Cecilia S, Chan J, Chang L, Iqbal R, et al.
JCI Insight
. 2017 May;
2(9.
PMID: 28469092
Background: Melanoma is a heterogeneous malignancy. We set out to identify the molecular underpinnings of high-risk melanomas, those that are likely to progress rapidly, metastasize, and result in poor outcomes....